Poster Abstract Session:
228. Antimicrobial Resistance Mechanisms
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Adult ID

Presentations:
1997
Daptomycin non-susceptible VRE: Problematic Pathogen or Misclassified Microbe?
Rachel V. Marini, PharmD ; Minh-Hong Nguyen, MD ; Ellen G. Press, MS ; Brian A. Potoski, PharmD ; Cornelius J. Clancy, MD ; Ryan K. Shields, PharmD
Posters
  • ID week 2016 lab.pdf (183.0 kB)
    • 1998
    Outcomes of Patients with Amp-C Inducible Enterobacteriaceae infections Treated with Carbapenems versus Cefepime or Piperacillin-tazobactam
    Meghan Jeffres, PharmD ; Clayton Foster, MD ; Bruce Mccollister, MD ; Randolph Fujit, PharmD ; Mary Bessesen, MD ; Michelle Barron, MD
    Posters
  • Carb vs. cefe and PT - BSI and PNA - ID Week.pdf (96.2 kB)
    • 1999
    Rapid detection and genotyping of antimicrobial resistance determinants with the BioFire FilmArray® System
    Jesse Montgomery, PhD ; Neil Draper, MS ; Andrew Hemmert, PhD ; Robert Crisp, PhD
    Posters
  • Montgomery_IDWeek 2016.pdf (1.1 MB)
    • 2000
    Assessment of the propensity of oritavancin to induce susceptibility changes among Staphylococcus aureus nasal carriage isolates in a Phase 2 study in patients with acute bacterial skin and skin structure infections
    Francis Arhin, Ph.D. ; Greg Moeck, Ph.D.
    Posters
  • Arhin and Moeck_2000.pdf (122.3 kB)
    • 2001
    Longitudinal Whole-Genome Analysis Identifies Variants Associated with Vancomycin and Linezolid Resistance Changes in Enterococcus faecium in Response to Treatment
    Kieran Chacko, BA, BS ; Theodore Pak, AB ; Robert Sebra, Ph.D. ; Andrew Kasarskis, PhD ; Camille Hamula, PhD ; Harm Van Bakel, PhD
    Posters
  • Kieran Chacko - ID Week Poster.pdf (3.7 MB)
    • 2002
    Determinants of Azole Resistance in Aspergillus
    Sanjeet Dadwal, MD ; Catherine Oak, MS ; Jane Kriengkauykiat, PharmD ; James Ito, MD ; Markus Kalkum, PhD
    2003
    Ceftazidime/avibactam and ceftolozane/tazobactam in treatment of pulmonary infections by Imipenem resistant Pseudomonas aeruginosa.
    Alina Iovleva, MD ; Federico Perez, MD ; Steve H. Marshall, MS ; Andrea M. Hujer, BS ; Michael R. Jacobs, MD, PhD ; Usha Stiefel, M.D. ; Amy Ray, MD, MPH ; Robert A. Bonomo, MD
    Posters
  • idweekv2 Alina.pdf (788.7 kB)
    • 2004
    Point mutations in domain V of the 23S rRNA gene are the primary cause of clarithromycin resistance in clinical Helicobacter pylori isolates in the United States
    Derrick Chen, MD ; Scott Cunningham, MT(ASCP), MS ; Nicolynn Cole, MT(ASCP) ; Peggy Kohner, MT(ASCP) ; Robin Patel, MD, FIDSA, D(ABMM)
    Posters
  • 161019 FINAL IDWeek Poster - H pylori 4x6.pdf (659.4 kB)
    • 2005
    Effect of Imipenem-Relebactam on sub-types of KPC in Klebsiella pneumoniae
    Katherine Young, MS ; Mary Motyl, PhD ; Daniel Tatosian, PhD
    2006
    Epidemiology of Azole-Resistance and CYP51A Mutations in Aspergillus Isolates Recovered from Lung Transplant Recipients who Received Voriconazole Prophylaxis
    Don Nguyen, B.S. ; Shaoji Cheng, PhD ; Cornelius Clancy, MD ; Minh-Hong Nguyen, MD
    2007
    Activity of Linezolid when Tested against Gram-Positive Isolates from the USA (Linezolid Experience and Accurate Determination of Resistance [LEADER]) from 2015
    Robert K. Flamm, Ph.D. ; Jennifer M. Streit, BS ; Rodrigo E. Mendes, PhD ; Helio S. Sader, MD, PhD ; Patricia a. Hogan, MBA
    Posters
  • IDWeek16 LEADER 2007.pdf (364.6 kB)
    • 2008
    Uropathogenic E. coli from Pakistan have High Prevalence of Multidrug Resistance, ESBL, and O25b-ST131
    Ihsan Ali, M.Phil ; Zara Rafaque, M.Phil ; Javid Iqbal Dasti, PhD ; Sarah E Graham, BS ; Elizabeth Salzman, MS ; Betsy Foxman, PhD, FIDSA
    2009
    Mechanisms of Quinolone Resistance in Enterotoxigenic Escherichia coli Isolates from Peruvian Children
    Fulton Rivera, MSc ; Anicia Medina, BSc ; Maria Pons, PhD ; Maribel Riveros, BSc ; Joaquim Ruiz, PhD ; Theresa Ochoa, MD
    Posters
  • ETEC quinolone IDWeek 26Oct2016.pdf (317.8 kB)
    • 2010
    Clonal Pan or Extensively Drug-Resistant KPC-2-Producing ST437 Klebsiella pneumoniae Causing Untreatable Infections Evidenced by In Vitro Synergy Testing
    Marisa Zenaide Ribeiro Gomes, MD, MSc, MBA, PhD ; Elisangela Martins De Lima, MD ; Polyana Silva Pereira, BMSc, MSc, PhD ; Caio Augusto Martins Aires, BMSc, MSc, PhD ; Maria José De Souza Menicalli, MD, PharmB ; Claudio Marcos Rocha De Souza, BSBio, MSc, PhD ; Rodolpho Mattos Albano, BSBio, MSc, PhD ; Juwon Yim, PharmD ; Ana Paula D'alincourt Carvalho Assef, BSBio, MSc, PhD ; Michael J. Rybak, PharmD, MPH ; Marise Dutra Asensi, BSBio, MSc, PhD
    Posters
  • AB PosterIDWEEK.pdf (668.0 kB)
    • 2011
    Daptomycin susceptibility of clinical isolates in invasive Staphylcoccus aureus infections in Korean hospitals: can resistance to daptomycin occur without previous exposure?
    Joo-Hee Hwang, MD ; Eun Young Nam, MD ; Soo-Jin Yang, PhD ; Eu Suk Kim, MD ; Kyung-Hwa Park, MD ; Sook-in Jung, MD ; Nara Yoon, MD ; Dong-Min Kim, M.D., PhD. ; Chang-Seop Lee, MD ; Hee-Chang Jang, MD ; Yoonseon Park, MD ; Kkot Sil Lee, MD ; Yee Gyung Kwak, MD ; Jae Hoon Lee, MD ; Seong Yeon Park, MD ; Moonsuk Kim, MD ; Kyoung-Ho Song, MD ; Hong Bin Kim, MD, PhD
    Posters
  • Dapto poster - IDWEEK 2016 - 황주희.pdf (396.4 kB)
    • 2012
    Accuracy of Cefepime (FEP) Susceptibility Testing of Ceftriaxone Non-Susceptible Enterobacteriaceae (CNSE) by Three Methods
    Anita Cheruvanky, M.D.
    Posters
  • cefepime_IDweek2016_ac1_ajm-2pdf.pdf (1.9 MB)
    • 2013
    Potential risk of horizontal dissemination of fluoroquinolone and cephalosporin resistance from commensal E. coli and Shigella spp. to Salmonella spp.
    Naveen Kumar Devanga Ragupathi, Ph.D. ; Dhiviya Prabaa Muthuirulandi Sethuvel, M.Sc. ; Revathi Gajendiran, M.Sc. ; Shalini Anandan, MD ; Kamini Walia, PhD ; Balaji Veeraraghavan, Ph.D.

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.